Benefit of single-injection Depot Progesterone before surgery in node positive breast cancer patients

  • 253 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
253
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Editoriale Page 1 of 1 Benefit of single-injection Depot Progesterone before surgery in node positive breast cancer patients This is the first randomized evidence suggesting benefit of short-term peri-operative hormone therapy (progesterone) in DFS and OS in node positive breast cancer. The results not only suggest an easily implementable cost-effective intervention in routine clinical practice but also offers some biological insights about when does metastases set in? and how modulation of events at the time of surgery affects a chronic disease?. In absence of side effects and low cost of intervention this would be the most effective intervention for the developing world as well as cash strapped health care systems globally. The results need to be reproduced in other parts of the world. Bibliographic Reference: Badwe R et al.: "Single-Injection Depot Progesterone Before Surgery and Survival in Women With Operable Breast Cancer: A Randomized Controlled Trial", J Clin Oncol. 2011 Jun 13. [Epub ahead of print] Raj Badwe Tata Memorial Hospital, Mumbai, Indiahttp://www.senology.org/Edit_Badwe.htm 09/09/2011